GAD2 and dentatorubral-pallidoluysian atrophy: On the other hand, antigen-loaded tolDCs-GAD65 and tolDCs-OVA prepared in SF conditions did not substantially decrease diabetes incidence in the NOD-SCID recipients, but this time tolDC-GAD65 and tolDC-OVA groups (Figure 3A) displayed a reversed pattern as in Figure 2.